BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS

July 29, 2024 -- InvestorsHub NewsWire -- Bounce Mobile Systems Inc. (BNCM) and DELEX Healthcare Group Inc. (DELEX) are pleased to announce their management plans following the merger announcement on July 2, 2024.

This strategic merger represents a significant milestone for both companies, aimed at combining their strengths to enhance operational efficiency and market reach which is set to drive innovation and growth in the healthcare industry. With a clear roadmap for regulatory compliance, asset transfer, and integrated management, DELEX is poised to deliver greater value to its stakeholders.

Roadmap for Post-Merger Success

Driven by a shared objective to elevate the pharmaceutical industry in the Philippines, BNCM and DELEX are setting their sights on strategically and seamlessly accomplishing future management plans to comply with all necessary procedures to finalize the merger. Key components of the post-merger management plan include:

1. Regulatory Compliance

The Board of Directors of both DELEX and BNCM will complete the required processes with the SEC, OTC Markets, and other relevant authorities. This step ensures that all regulatory processes are met, paving the way for a smooth and compliant transition. The commitment to adhering to regulatory standards underscores the companies' dedication to maintaining transparency and integrity throughout the merger process.

2. Asset Transfer

BNCM will submit the list of DELEX's assets on its 3^rd. Quarterly Report. This submission will detail all relevant assets, ensuring clarity and transparency for regulators and stakeholders. The accurate and timely transfer of assets is crucial for the successful integration of operations and the continued growth of the merged entity.

3. Corporate Rebranding

BNCM will seek approval from the SEC, OTC Markets, and other relevant authorities to rename BNCM to Delex Healthcare Group Inc. (DELEX). The rebranding reflects the vision and strategic direction of the company. This signifies the combined strength and commitment to becoming a leading player in the healthcare sector, delivering innovative and cost-effective solutions to a global market.

4. Management and Operations Integration:

All management, operations, and expansion plans will be fully transferred and managed by the DELEX within the next 3 to 6 months. This integration will ensure that the merged entity operates seamlessly, leveraging the strengths and expertise of both companies. The comprehensive transfer of responsibilities will enable DELEX to execute its expansion plans effectively and drive sustained growth.

5. Expansion Plans:

DELEX will continue its expansion plans as outlined in the press release issued on July 15, 2024. These plans focus on developing a broader range of products, expanding global distribution channels, and consistently delivering quality and cost-effective medicines and medical devices to its hospital partners. Detailed information about these initiatives can also be found on the company's website, ensuring transparency and accessibility for all stakeholders.

6. Ongoing Communication:

BNCM and DELEX will issue a series of press releases on the OTC Market platform and major media outlets in the coming weeks. These communications will keep all stakeholders informed about the progress and developments of the merger. Regular updates will ensure that investors, partners, and customers remain well-informed about the strategic direction and milestones of the newly formed Delex Healthcare Group Inc.

A Promising Future

This merger between DELEX and BNCM marks a pivotal milestone for both parties. DELEX is poised to continue its expansion, developing a broader range of products, expanding global distribution channels, and consistently leading the market in delivering quality and cost-effective medicines and medical devices to its hospital partners.

With the government's continued support to foster the growth and competitiveness of the industry, and leveraging the combined expertise of both companies, the merger is set to achieve new heights in the coming years. This merger promises significant benefits to current and future investors and shareholders, enhancing the company's financial stability and growth prospects, and generating greater returns and value for their investments.

About Bounce Mobile Systems, Inc. (OTC: BNCM)

BNCM is an Asset Management Company that secures its assets by investing in companies with strong growth potentials, robust revenues, significant profits, proven track records, and promising business models with highly experienced management teams that will exceptionally qualify for quotation and or listing on the OTC and or NASDAQ Market within the next 2 to 3 years. The growth of these companies will directly provide more employment opportunities to the communities, improve the country's economy, and bring greater social change to humanity.

For more information, visit: https://www.bncm.net/

About Delex Healthcare Group, Inc. (DELEX)

DELEX is a Delaware-registered company, and a holding company of DLX Holdings, Inc. (DLX). DLX is a Philippine-based parent company that holds a 60% controlling interest in Delex Pharma International, Inc. while also holding a 46% controlling interest in JMN Brother's Pharma Limited, Inc. DLX and its subsidiaries are involved in the development and distribution of pharmaceutical and healthcare products in the Philippines.

For more information, visit: https://delexhealth.com

Bounce Mobile Systems (PK) (USOTC:BNCM)
Historical Stock Chart
From Jun 2024 to Jul 2024